Astech Projects Launch REACTS™ - a Rapid, Effective And Complete Technical Support service

26 Mar 2008

Product news

Leading automation developer, Astech Projects, has today announced the launch of its new automation maintenance service - REACTS™: Rapid, Effective And Complete Technical Support. Combining Astech’s long-standing automation experience and extensive engineering expertise, REACTS is an extension of the high quality customer service for which Astech is well known. In addition to existing Astech automation specialists, the company has recruited four highly respected engineers with many years’ experience working with top 10 pharma companies worldwide. The new REACTS team will provide automation installation and maintenance services, and technical support for any automation system in the drug discovery and pharmaceutical manufacturing sectors throughout Europe, North America and Asia.

Astech Projects’ Sales & Marketing Director, Anthony Moran, commented, “REACTS has really evolved from a service that we are already providing our customers. Now with a larger, dedicated team that is solely devoted to this service we can provide support on a truly global scale for the all existing automation, including third party systems.” He continued, “Our new team has an excellent background and brings with it in-depth industry knowledge. This is an essential requirement for our REACTS service and their expertise compliments our highly proficient team of mechanical, electrical, control and software engineers.”

With superior capabilities in the development of bespoke automation and products for high throughput pharmaceutical research and manufacturing testing, Astech Projects has built a strong reputation in the industry. Specific areas include the development and supply of advanced automation for high throughput (HT) compound management and retrieval, high throughput screening (HTS) and automated drug delivery testing. For further information on the new REACTS service in addition to the scope of automation solutions available, please visit the article webpage.

Links

Tags

High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Microplate Readers / DetectorsMicroplate readers are used to automate the detection and analysis of labeled or label-free components in microplates during assays or live-cell monitoring. Microplate readers are generally distinguished by their mode of detection. Types include absorbance, luminescence, fluorescence intensity, fluorescence polarization, TRF / FRET and multimode microplate readers. Microplate readers deliver a high throughput of samples by reading multiple wells simultaneously, with the 96-well format the most commonly used. As a result, microplate readers are often used in the drug discovery, bioassays, research and pharmaceutical industries for screening applications. Microplate loading can also be automated, with robotic microplate stackers to increase throughput. Find the best microplate readers in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Integration ServicesIncorporate lab systems, software and equipment with integration services.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Compound AnalysisCompound analysis is used to discover specific compounds that could be promising candidates for pharmaceutical use. This potential is identified when compounds have the desired effect, such as interaction with a target protein, during high throughput screening.